Hypertrophic cardiomyopathy - Symptoms and causes - Mayo Clinic
2024年2月23日 · Hypertrophic cardiomyopathy (HCM) is a disease in which the heart muscle becomes thickened, also called hypertrophied. The thickened heart muscle can make it harder for the heart to pump blood. Many people with hypertrophic cardiomyopathy don't realize they have it. That's because they have few, if any, symptoms.
Hypertrophic Obstructive Cardiomyopathy - StatPearls - NCBI Bookshelf
2022年10月31日 · HOCM is a significant cause of sudden cardiac death in young people, including well-trained athletes, affecting men and women equally across all races. In most patients, it results from asymmetric septal hypertrophy, causing outflow obstruction of …
Hypertrophic cardiomyopathy - Wikipedia
Hypertrophic cardiomyopathy (HCM, or HOCM when obstructive) is a condition in which muscle tissues of the heart become thickened without an obvious cause. [8] The parts of the heart most commonly affected are the interventricular septum and the ventricles. [10]
Hypertrophic Cardiomyopathy (HCM) - American Heart Association
2024年5月29日 · The American Heart Association explains hypertrophic cardiomyopathy (HCM) including obstructive and nonobstructive HCM. Also learn symptoms, diagnosis and treatment for HCM.
Hypertrophic Cardiomyopathy: Causes, Symptoms & Treatments
What is hypertrophic cardiomyopathy (HCM)? Hypertrophic cardiomyopathy (HCM) is a complex type of heart disease that affects your heart muscle. It can cause: Thickening of your heart muscle (especially the ventricles or lower heart chambers). Left ventricular stiffness. Mitral valve changes. Cellular changes. Advertisement.
Hypertrophic cardiomyopathy: Management of patients with ... - UpToDate
2024年7月31日 · Hypertrophic cardiomyopathy (HCM) is a genetically determined disease that commonly results in obstruction of the left ventricular outflow tract (LVOT), which can produce chest discomfort, dyspnea, fatigue, and syncope. This topic discusses the management of patients with HCM and symptoms attributable to LVOT obstruction.
Hypertrophic cardiomyopathy: Clinical manifestations, diagnosis, …
2022年10月4日 · INTRODUCTION. Hypertrophic cardiomyopathy (HCM) is a genetically determined heart muscle disease most often (60 to 70 percent) caused by mutations in one of several sarcomere genes which encode components of the contractile apparatus of the heart.
Hypertrophic cardiomyopathy - Diagnosis and treatment - Mayo Clinic
2024年2月23日 · Blood thinners such as warfarin (Jantoven), dabigatran (Pradaxa), rivaroxaban (Xarelto) or apixaban (Eliquis). Blood thinners can help prevent blood clots if you have atrial fibrillation or the apical type of hypertrophic cardiomyopathy. Apical HCM can raise the risk of sudden cardiac death.
Hypertrophic Cardiomyopathy (HCM) • LITFL • ECG Library …
6 天之前 · Hypertrophic cardiomyopathy, previously termed hypertrophic obstructive cardiomyopathy (HOCM) or idiopathic hypertrophic subaortic stenosis (IHSS), is one of the most common inherited cardiac disorders: Prevalence ~1 in 500 people; Annual mortality ~1-2%; Number one cause of sudden cardiac death in young people
Hypertrophic Cardiomyopathy - Hypertrophic Cardiomyopathy …
A cardiomyopathy is a primary disorder of the heart muscle (see also Overview of Cardiomyopathies.) Hypertrophic cardiomyopathy is a common cause of sudden death in young athletes. It may cause unexplained syncope and may not be diagnosed before autopsy.